Acute Ischemic Stroke: Clinical Features, Investigation, and Management
Acute ischemic stroke is a medical emergency requiring immediate recognition and treatment within minutes to hours, with intravenous thrombolysis (alteplase or tenecteplase) within 4.5 hours and endovascular thrombectomy up to 24 hours for eligible patients being the only proven treatments to reduce death and disability. 1, 2
Clinical Features
Recognition of Stroke Symptoms
The hallmark is sudden onset of focal neurological deficits. Key features to identify include:
- Motor deficits: Unilateral weakness or paralysis (hemiplegia/hemiparesis) of face, arm, or leg
- Speech disturbances: Aphasia (inability to speak or understand) or dysarthria (slurred speech)
- Sensory loss: Hemisensory deficits
- Visual changes: Hemianopia, diplopia, or sudden vision loss
- Coordination problems: Ataxia, vertigo, or gait disturbance
- Altered consciousness: In severe cases, particularly with large vessel occlusion
Severity Assessment
Use the National Institutes of Health Stroke Scale (NIHSS) immediately to quantify neurological deficits and guide treatment decisions. Higher scores suggest large vessel occlusion requiring endovascular therapy. 5
Critical Time Points
- Time of symptom onset is the single most important piece of information—this determines treatment eligibility
- For patients who wake up with symptoms, the "last known normal" time is used
- Every 30-minute delay in recanalization decreases good functional outcome by 8-14% 1
Investigation
Immediate Imaging (Door-to-Imaging Goal: <20 minutes)
Non-contrast CT (NCCT) of the head is the first-line imaging modality because it is fast, widely available, and answers the three critical questions: 1
- Is there intracranial hemorrhage? (Excludes thrombolytic therapy)
- Is there a vessel occlusion and where? (Requires CT angiography)
- What is the extent of established infarction? (Risk-benefit assessment)
Advanced Imaging for Extended Time Windows
CT perfusion (CTP) or MRI with diffusion-weighted imaging (DWI) should be obtained when:
- Patients present 6-24 hours from symptom onset
- Wake-up strokes with unclear onset time
- Evaluating for large-core infarction versus salvageable penumbra
These modalities identify patients with favorable tissue profiles (small core, large penumbra) who may benefit from thrombectomy despite extended time windows. 1, 2, 6
Vascular Imaging
CT angiography (CTA) from aortic arch to vertex should be performed immediately in all suspected stroke patients to:
- Identify large vessel occlusion (LVO) requiring endovascular therapy
- Assess collateral circulation
- Detect tandem lesions or dissection
Laboratory Studies
Obtain immediately:
- Glucose (hypoglycemia mimics stroke; hyperglycemia worsens outcomes)
- Complete blood count (thrombocytopenia contraindication)
- Coagulation studies (INR, aPTT if anticoagulated)
- Troponin and ECG (cardiac comorbidities, atrial fibrillation)
Management
Airway, Breathing, Circulation
- Maintain oxygen saturation >94%
- Avoid intubation unless absolutely necessary (aspiration risk, declining consciousness)
- Establish IV access immediately
Blood Pressure Management
Critical distinction based on reperfusion therapy eligibility: 2
For patients receiving IV thrombolysis:
- Must lower BP to <185/110 mmHg BEFORE treatment
- Maintain BP <180/105 mmHg for 24 hours AFTER treatment
- Use labetalol, nicardipine, or clevidipine for rapid control
For patients receiving endovascular therapy:
- Target <185/110 mmHg before procedure
- After successful thrombectomy: avoid intensive BP lowering
- Target SBP 140-180 mmHg (intensive lowering to <130 mmHg increases mortality) 2
For patients NOT receiving reperfusion therapy:
- Permissive hypertension: do NOT lower BP unless >220/120 mmHg
- Spontaneous BP lowering occurs in 75% within 48-72 hours
- Active BP lowering does not improve outcomes and may worsen them 2
Intravenous Thrombolysis
Offer IV alteplase (0.9 mg/kg, maximum 90 mg) OR tenecteplase to eligible patients within 4.5 hours of symptom onset. 9, 10, 2
Inclusion criteria:
- Measurable neurological deficit
- Symptom onset <4.5 hours (or wake-up stroke with favorable imaging)
- Age ≥18 years
- CT excludes hemorrhage
Key exclusion criteria:
- BP >185/110 mmHg (refractory to treatment)
- Recent major surgery, trauma, or GI/GU bleeding
- Prior intracranial hemorrhage
- Active bleeding or bleeding diathesis
- Platelets <100,000
- INR >1.7, aPTT elevated
- Glucose <50 mg/dL
Additional exclusions for 3-4.5 hour window:
- Age >80 years
- NIHSS >25
- Oral anticoagulant use
- History of both diabetes and prior stroke
Administration:
- 10% as bolus over 1 minute
- Remaining 90% as infusion over 60 minutes
- No antiplatelet or anticoagulant therapy for 24 hours post-tPA
Endovascular Thrombectomy (EVT)
Perform mechanical thrombectomy for large vessel occlusion (internal carotid artery, M1/proximal M2 middle cerebral artery) in eligible patients up to 24 hours from last known normal. 1, 2
Eligibility criteria (0-6 hours):
- Large vessel occlusion on CTA
- NIHSS ≥6
- Pre-stroke independence (mRS 0-1)
- Small to moderate infarct core
Extended window (6-24 hours):
- Requires advanced imaging (CTP or MRI)
- Favorable perfusion profile (small core, large penumbra)
- ASPECTS score or automated software assessment
Technique:
- Combined approach using stent-retrievers PLUS aspiration achieves fastest first-pass complete reperfusion 1
- Door-to-groin puncture goal: <90 minutes
Antiplatelet Therapy
For patients NOT receiving thrombolysis:
- Aspirin 160-325 mg within 24-48 hours of symptom onset (small but definite benefit)
- Reduces early recurrent stroke by approximately 1%
For minor stroke (NIHSS ≤3) or high-risk TIA:
- Dual antiplatelet therapy (aspirin + clopidogrel) for 21 days, then aspirin alone
- Reduces early recurrence risk 11
Avoid These Interventions
Do NOT use:
- Corticosteroids (no benefit for cerebral edema) 8
- Urgent anticoagulation (increases hemorrhage risk without reducing recurrence) 8
- Neuroprotective agents (none proven effective) 8
- Prophylactic anticonvulsants (only treat if seizures occur) 8
Complications Management
Malignant cerebral edema:
- Occurs in 10-20% of large hemispheric infarctions
- Decompressive hemicraniectomy within 48 hours is life-saving for patients <60 years with MCA territory infarction
- Osmotherapy (mannitol, hypertonic saline) and hyperventilation as temporizing measures 8
Cerebellar infarction with mass effect:
- Urgent neurosurgical decompression and/or ventriculostomy for brainstem compression or hydrocephalus 8
Hemorrhagic transformation:
- Occurs in ~5% spontaneously, higher with thrombolytics
- Symptomatic hemorrhage requires reversal of anticoagulation, BP control, neurosurgical consultation 8
Systems of Care
Prehospital:
- Activate EMS (9-1-1) immediately—EMS patients arrive faster and within treatment windows
- Prehospital stroke scales identify LVO candidates
- Mobile stroke units with onboard CT expand treatment access 12, 3
Hospital:
- Stroke team activation upon EMS notification
- Door-to-needle time goal: <60 minutes (ideally <45 minutes)
- Door-to-groin puncture: <90 minutes
- Direct transfer to thrombectomy-capable centers for suspected LVO 3, 2
Common Pitfalls
- Delaying treatment for "complete workup"—imaging should answer only the three critical questions; do not wait for MRI, echocardiogram, or extensive labs
- Overly aggressive BP lowering—permissive hypertension maintains penumbral perfusion in non-thrombolysis candidates
- Excluding patients based on age alone—advanced age is not an absolute contraindication if otherwise eligible
- Missing wake-up strokes—these patients may be candidates with advanced imaging
- Administering antiplatelet/anticoagulant therapy within 24 hours of tPA—significantly increases hemorrhage risk